GERD (acid reflux) decisions — 2025

The Board denied the veteran's claims for service connection for gastroesophageal reflux disease (GERD) and obstructive sleep apnea (OSA) as there is no current diagnosis of either condition.

The appeal for an initial compensable disability rating for gastroesophageal reflux disease (GERD) was dismissed due to a prohibited concurrent election of administrative review options.

The Board denied service connection for bilateral hearing loss, PTSD, and a bilateral eye condition. The back, bilateral hip, hypertension, GERD, migraine disorder, penile condition, and sleep apnea claims were remanded.

The Board remands the claims for service connection for acoustic neuroma/vestibular schwannoma, Barrett's esophagus/gastroesophageal reflux disease, and mucous retention cysts to obtain an adequate medical opinion regarding their nature and etiology.

The Board denied the veteran's claims for increased ratings and service connection due to his failure to report for scheduled VA examinations without good cause.

The Veteran's claim for an earlier effective date for the grant of service connection for left side sciatica was granted, and several issues were remanded due to a duty to assist error.

The Board granted a 50 percent rating for generalized anxiety disorder with panic disorder and migraine headaches, restored the 30 percent rating for GERD with irritable bowel syndrome (IBS), and granted earlier effective dates for total disability rating for compensation based on individual unemployability due to service-connected disabilities (TDIU) and eligibility to Dependents' Educational Assistance.

The Veteran withdrew the appeal for an initial rating higher than 10 percent for GERD.

The Board remands the claim for an in-person examination to properly assess the nature and severity of the Veteran's service-connected GERD.

The Veteran withdrew his appeals for service connection for depression, gastroesophageal reflux disease (GERD), and hypertension, claimed as high blood pressure.

The Board granted an initial 50 percent disability rating for migraine headache and a 60 percent disability rating for gastroesophageal reflux disease (GERD) effective April 19, 2022.

The Board granted a 50 percent rating for migraine headaches and remanded the claim for an increased rating for GERD, mild hiatal hernia, and erosive esophagitis. Other claims were denied.

The Veteran's appeal request was denied as it was not timely filed within one year of the rating decision.

The Board granted a rating of 60 percent for the Veteran's gastroesophageal reflux disease, as it was productive of severe impairment of health.

The Board denied initial compensable ratings for testicular atrophy with male sterility and hypogonadism, deviated septum, migraines, and hypothyroidism. A 100 percent rating was granted for Meniere's syndrome.

The Board denied service connection for GERD, IBS, hemorrhoids, and pregnancy as the evidence did not support a nexus to military service. The claims for neck pain, back pain, bilateral foot pain, bilateral shoulder pain, bilateral wrist pain, bilateral hand pain, bilateral hip pain, bilateral knee pain, and bilateral ankle pain were remanded.

The Board remands the claim for a new VA examination to determine the current severity of the Veteran's GERD without the ameliorative effects of medication.

The Board granted service connection for a functional gastrointestinal disorder manifest by symptoms other than those attributable to GERD and headaches, both on a presumptive basis under the PACT Act due to the Veteran's qualifying service in the Southwest Asia theater of operations during the Gulf War period.

The Board remands the case to the RO for another medical opinion to clarify the likely etiology of the Veteran's currently diagnosed GERD.

The Board denied service connection for a sleep disability, endometriosis, and a heart disability. The rating assigned was 40 percent for right upper extremity radiculopathy from March 27, 2018, and 30 percent for left upper extremity radiculopathy from July 3, 2017.